ESTABLISHMENT AND CHARACTERIZATION OF AN UVEAL-MELANOMA CELL-LINE

被引:182
作者
DEWAARDSIEBINGA, I
BLOM, DJR
GRIFFIOEN, M
SCHRIER, PI
HOOGENDOORN, E
BEVERSTOCK, G
DANEN, EHJ
JAGER, MJ
机构
[1] UNIV LEIDEN HOSP,DEPT CLIN ONCOL,2300 RC LEIDEN,NETHERLANDS
[2] UNIV LEIDEN HOSP,DEPT CLIN CYTOGENET,2300 RC LEIDEN,NETHERLANDS
[3] UNIV NIJMEGEN HOSP,DEPT PATHOL,NIJMEGEN,NETHERLANDS
关键词
D O I
10.1002/ijc.2910620208
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A human uveal melanoma cell line (92-1) was established from a primary uveal melanoma, and has now been maintained in culture for over 21/2 years. Light microscopy of the cultured cells demonstrated extremely pleiomorphic cells with large prominent nucleoli. Cell proliferation was determined with a non-radioactive propidium-iodide assay and indicated an in vitro doubling time of approximately 58 hr. Furthermore, the cell line was characterized by cytogenetic analysis, electron microscopy, immunocytochemistry and Northern blotting for HLA and c-myc-mRNA analysis. Cytogenetic analysis revealed numerical abnormalities of chromosome 8 and structural abnormalities of chromosome 6. By electron microscopy, different stages of melanosome development were observed. Immunocytochemical analysis demonstrated expression of the melanoma-associated antigen gp100. Expression analysis of HLA antigens revealed a very low level of, in particular, the HLA-B locus products, which could be induced by interferon-alpha or -gamma treatment. Likewise, Northern-blot experiments revealed decreased levels of HLA-B mRNA as compared with HLA-A. In addition, high levels of c-myc expression were observed. The phenotypic characteristics of the cultured cells indicate that we have established an uveal melanoma cell line. This now well-characterized uveal melanoma cell line can be used in future studies. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:155 / 161
页数:7
相关论文
共 51 条
[1]  
ALBELDA SM, 1993, LAB INVEST, V68, P4
[2]  
ALBERT DM, 1984, INVEST OPHTH VIS SCI, V25, P1284
[3]  
BARISHAK YR, 1960, ARCH OPHTHALMOL-CHIC, V64, P352
[4]   PRODUCTION OF MONOCLONAL ANTIBODIES TO GROUP-A ERYTHROCYTES, HLA AND OTHER HUMAN CELL-SURFACE ANTIGENS - NEW TOOLS FOR GENETIC-ANALYSIS [J].
BARNSTABLE, CJ ;
BODMER, WF ;
BROWN, G ;
GALFRE, G ;
MILSTEIN, C ;
WILLIAMS, AF ;
ZIEGLER, A .
CELL, 1978, 14 (01) :9-20
[5]   MONOCLONAL-ANTIBODY TO HLA-A3 [J].
BERGER, AE ;
DAVIS, JE ;
CRESSWELL, P .
HYBRIDOMA, 1982, 1 (02) :87-90
[6]   PHENOTYPIC DYNAMICS OF TUMOR PROGRESSION IN HUMAN-MALIGNANT MELANOMA [J].
BROCKER, EB ;
SUTER, L ;
BRUGGEN, J ;
RUITER, DJ ;
MACHER, E ;
SORG, C .
INTERNATIONAL JOURNAL OF CANCER, 1985, 36 (01) :29-35
[7]   CHARACTERIZATION OF A MONOCLONAL ANTI-BETA-2-MICROGLOBULIN ANTIBODY AND ITS USE IN THE GENETIC AND BIOCHEMICAL-ANALYSIS OF MAJOR HISTOCOMPATIBILITY ANTIGENS [J].
BRODSKY, FM ;
BODMER, WF ;
PARHAM, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1979, 9 (07) :536-545
[8]  
BRUNING JW, 1983, HUM IMMUNOL, V8, P305
[9]   IDENTIFICATION AND NUCLEOTIDE-SEQUENCE OF A HUMAN LOCUS HOMOLOGOUS TO THE V-MYC ONCOGENE OF AVIAN MYELOCYTOMATOSIS VIRUS MC29 [J].
COLBY, WW ;
CHEN, EY ;
SMITH, DH ;
LEVINSON, AD .
NATURE, 1983, 301 (5902) :722-725
[10]   THE OSTEOCLAST FUNCTIONAL ANTIGEN, IMPLICATED IN THE REGULATION OF BONE-RESORPTION, IS BIOCHEMICALLY RELATED TO THE VITRONECTIN RECEPTOR [J].
DAVIES, J ;
WARWICK, J ;
TOTTY, N ;
PHILP, R ;
HELFRICH, M ;
HORTON, M .
JOURNAL OF CELL BIOLOGY, 1989, 109 (04) :1817-1826